January 2026 – A New Year and Bright Road Ahead!
A New Year and Bright Road Ahead! Dear Partners, I’m beginning my first full year leading Lycored feeling inspired by the significant milestones of 2025: Our...
Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer
May 30, 2024
In a prospective study we evaluated the efficacy of lycopene for the treatment of patients with metastatic hormone refractory prostate cancer.
File Type:
www
Categories:
Lycomato
Continue reading
December 2025 – Introducing Lumenato and Lycoderm to the European Union
Two of our powerhouse beauty from within solutions — both derived from tomatoes —made the European Food Safety Authority (EFSA) list of novel foods and are officially available for sale...
November 2025 Newsletter – Our most versatile solution 🤝 Your latest product formulation
Breaking news - One ingredient, many solutions! Our new VAS (versatile application solution) technology hit the market November 6th.
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.